Adelheid F. Cerwenka
Mannheim, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 91 publications
Accelerating Translation of NK Cell Therapies to the Clinic: A European Perspective.
Journal: Human gene therapy
Published: August 03, 2026
Tissue-Specific Spatial Regulation of Innate Immune Checkpoints in Cancer.
Journal: Cancer discovery
Published: November 27, 2025
Colorectal cancer organoids drive hypoxia, TGF-β, and patient-specific diversification of NK cell activation programs.
Journal: Journal for immunotherapy of cancer
Published: November 18, 2025
Functional segregation of HIF-1α and AhR controls NK cell responsiveness under hypoxia.
Journal: iScience
Published: August 18, 2025
S100A9 and HMGB1 orchestrate MDSC-mediated immunosuppression in melanoma through TLR4 signaling.
Journal: Journal for immunotherapy of cancer
Published: August 01, 2024
IFNγ mediates the resistance of tumor cells to distinct NK cell subsets.
Journal: Journal for immunotherapy of cancer
Published: June 07, 2024
The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance.
Journal: Science immunology
Published: May 03, 2024
Last Updated: 09/26/2026